Phase 3 Osteoarthritis Trial, Recruiting NCT06578182 Sponsor: Sint Maartenskliniek Condition: Osteoarthritis
Back to Osteoarthritis

Phase 3 Osteoarthritis Trial, Recruiting

NCT06578182
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with osteoarthritis (OA) of the knee or hip
  • People aged between 45 and 80 years old
  • People who have X-ray findings showing moderate to advanced knee or hip OA (based on a standard scoring system called Kellgren & Lawrence, score of 2 or higher), OR people who have had knee or hip OA symptoms for at least 2 years

Who may not be able to join:

  • People who are already on a waiting list for a first-time hip or knee replacement surgery, for any reason
  • People for whom hip or knee replacement surgery would never be a future option, due to any absolute medical reason
  • People who have already had more than one previous hip or knee replacement
  • People with another known medical condition that affects the joints
  • People with known widespread pain conditions, such as fibromyalgia
  • People with kidney problems, shown by specific blood test results above certain levels (confirm with trial site)
  • People with liver problems, shown by a specific liver enzyme blood test result above a certain level (confirm with trial site)
  • People with blood disorders
  • People who are considered highly frail (rated 7 or above on a standard frailty scale) or who have a life expectancy of less than 5 years
  • People with nerve inflammation, muscle inflammation, or a known significant sensitivity to statin medications
  • People currently taking colchicine for another medical condition
  • People who have a known intolerance to colchicine
  • People currently taking certain medications, including some antibiotics (such as clarithromycin, erythromycin, or azithromycin), some antifungal medicines, certain HIV medications, some heart rhythm medications (such as verapamil or diltiazem), or immunosuppressant drugs such as cyclosporine (confirm with trial site if unsure about current medications)
  • People who are currently enrolled in another clinical trial
  • People who are unable to make decisions for themselves
  • People who are pregnant or breastfeeding
  • People who are female and capable of becoming pregnant but are not using adequate contraception
  • Male participants who are unwilling to use effective contraception during the study to prevent pregnancy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +31633036353

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Sint Maartenskliniek
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 March 2029

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Time to first knee or hip replacement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov